Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders (Q73264754)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594551%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594551%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

A C Powers

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594551%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

K Bavik

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594551%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Tremble

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594551%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

K Daw

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594551%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

W A Scherbaum

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594551%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J P Banga

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594551%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 December 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594551%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594551%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594551%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594551%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

349-356

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594551%20AND%20SRC:MED&resulttype=core&format=json

Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase

2 November 2019

cites work

1 reference

12 December 2020

Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients

1 reference

12 December 2020

Autoimmunity to glutamic acid decarboxylase (GAD) in stiffman syndrome and insulin-dependent diabetes mellitus

1 reference

12 December 2020

Glutamate decarboxylase: an autoantigen in IDDM.

1 reference

12 December 2020

Antibodies to Glutamic Acid Decarboxylase Discriminate Major Types of Diabetes Mellitus

1 reference

12 December 2020

Antibodies to GAD and Tryptic Fragments of Islet 64K Antigen as Distinct Markers for Development of IDDM: Studies With Identical Twins

1 reference

12 December 2020

Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen

1 reference

12 December 2020

Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes

1 reference

12 December 2020

Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome

1 reference

12 December 2020

Human monoclonal islet specific autoantibodies share features of islet cell and 64 kDa antibodies

1 reference

12 December 2020

Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes

1 reference

12 December 2020

Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome

1 reference

12 December 2020

GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes

1 reference

12 December 2020

High level of concordance between assays for glutamic acid decarboxylase antibodies. The First International Glutamic Acid Decarboxylase Antibody Workshop

1 reference

12 December 2020

Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes

1 reference

12 December 2020

Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.

1 reference

12 December 2020

Mouse or man. Is GAD the cause of type I diabetes?

1 reference

12 December 2020

Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes

1 reference

12 December 2020

The pathogenesis of insulin-dependent diabetes mellitus

1 reference

12 December 2020

Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR(alpha1*0101,beta1*0401) transgenic mice.

1 reference

12 December 2020

Human B Cells Secreting Immunoglobulin G to Glutamic Acid Decarboxylase-65 from a Nondiabetic Patient with Multiple Autoantibodies and Graves’ Disease: A Comparison with Those Present in Type 1 Diabetes1

1 reference

12 December 2020

Positional cloning of the APECED gene

1 reference

12 December 2020

Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies

1 reference

12 December 2020

Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome

1 reference

12 December 2020

Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop

1 reference

12 December 2020

High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase

1 reference

12 December 2020

Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type

1 reference

12 December 2020

Autoimmune polyglandular syndromes

1 reference

12 December 2020

Autoantibodies in IDDM primarily recognize the 65,000-M(r) rather than the 67,000-M(r) isoform of glutamic acid decarboxylase

1 reference

12 December 2020

Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase

1 reference

12 December 2020

Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression

1 reference

12 December 2020

Heterogeneity of autoantibodies in stiff-man syndrome

1 reference

12 December 2020

Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus

1 reference

12 December 2020

Two distinct glutamic acid decarboxylase auto-antibody specificities in IDDM target different epitopes

1 reference

12 December 2020

Association between Antibodies to the MR 67,000 Isoform of Glutamate Decarboxylase (GAD) and Type 1 (Insulin-Dependent) Diabetes Mellitus with Coexisting Autoimmune Polyendocrine Syndrome Type II

1 reference

12 December 2020

Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition

1 reference

12 December 2020

The clinical significance of an autoimmune response against glutamic acid decarboxylase

1 reference

12 December 2020

Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.

1 reference

12 December 2020

Mapping of an autoreactive epitope within glutamate decarboxylase using a diabetes-associated human monoclonal autoantibody and an epitope cDNA library

1 reference

12 December 2020

T cells with multiple fine specificities are used by non-obese diabetic (NOD) mice in the response to GAD(524-543).

1 reference

12 December 2020

T cell clones to epitopes of glutamic acid decarboxylase 65 raised from normal subjects and patients with insulin-dependent diabetes

1 reference

12 December 2020

Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM.

1 reference

12 December 2020

Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase

1 reference

12 December 2020

Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401.

1 reference

12 December 2020

Insulin-dependent diabetes mellitus: the hypothesis of molecular mimicry between islet cell antigens and microorganisms

1 reference

12 December 2020

Identification of autoantibody epitopes of glutamic acid decarboxylase in stiff-man syndrome patients

1 reference

12 December 2020

T-cell reactivity to GAD65 peptide sequences shared with coxsackie virus protein in recent-onset IDDM, post-onset IDDM patients and control subjects

1 reference

12 December 2020

Identification of immunogenic epitopes of GAD 65 presented by Ag7 in non-obese diabetic mice

1 reference

12 December 2020

Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus

1 reference

12 December 2020